Webinar
ReciBioPharm - An optimized Plasmid DNA platform to accelerate the path to clinic and commercialization
![An optimized Plasmid DNA platform to accelerate the path to clinic and commercialization](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_large/publications/pharmaceutical-science/biopharma-reporter.com/library/recibiopharm-an-optimized-plasmid-dna-platform-to-accelerate-the-path-to-clinic-and-commercialization/16617828-1-eng-GB/ReciBioPharm-An-optimized-Plasmid-DNA-platform-to-accelerate-the-path-to-clinic-and-commercialization.jpg)
Assessing key parameters of the upstream process to achieve high titer while maintaining desired integrity
Customizing the downstream process to address the different needs from supercoil plasmid and linear isoform
A platform approach with integrated processes and analytical toolboxes to accelerate plasmid development to manufacturing